Taysha Gene Therapies Competitors and Similar CompaniesClear all
Taysha Gene Therapies's competitors and similar companies include Voyager Therapeutics, Lacerta Therapeutics, Passage Bio and apceth Biopharma.
 Voyager Therapeutics Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS). |  Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. |  apceth Biopharma apceth Biopharma is a contract development and manufacturing organization focused on cell and gene therapy. | |||
Founding Date | Founding Date 2020 | Founding Date 2014 | Founding Date 2017 | Founding Date 2018 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Dallas, US HQ | Locations Cambridge, US HQ | Locations Alachua, US HQ Alachua, US | Locations Philadelphia, US HQ | Locations Ottobrunn, DE HQ München, DE |
Employees | Employees 5220% decrease | Employees 16230% increase | Employees 13 | Employees 20 | Employees 234% decrease |
Valuation ($) | Valuation ($) 385.3 m | Valuation ($) 382.8 m | Valuation ($) N/A | Valuation ($) 39.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $9.8m (FY, 2025) | Revenue (est.) $40.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($109m) (FY, 2025) | Net income ($119.7m) (FY, 2025) | Net income N/A | Net income ($45.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 125m | Total funding raised $ 135m | Total funding raised $ 30m | Total funding raised $ 225.5m | Total funding raised $ 6.4m |
For sources of this data, please see the company profile
View Company Profiles
Voyager Therapeutics
HQ
Cambridge, US
Employees
162↑ 30% increase
Voyager Therapeutics is a gene therapy company developing treatments for diseases of the central nervous system (CNS).
View company
Lacerta Therapeutics
HQ
Alachua, US
Employees
13
Lacerta Therapeutics is a clinical stage gene therapy company.
View companyPassage Bio
HQ
Philadelphia, US
Employees
20
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
View companyapceth Biopharma
HQ
Ottobrunn, DE
apceth Biopharma is a contract development and manufacturing organization focused on cell and gene therapy.
View company